Mphasis, Emcure Pharma, Paytm Stocks See Over ₹6,800 Crore Block Deals as PE Firms Exit

Overview

Private equity firms offloaded significant stakes in Mphasis, Emcure Pharmaceuticals, and Paytm through block deals totaling over ₹6,800 crore on Tuesday. Blackstone sold a substantial portion of its Mphasis holding, while SAIF Partners and Bain Capital also divested stakes in Paytm and Emcure, respectively. Mutual funds emerged as key buyers in some of these large transactions.